PM2.5 induced neurodegenerative-like changes in mice and the antagonistic effects of vitamin E

Xudong Liu1, Yuchao Zhang1, Xu Yang1,2

  • 1Department of Food science and Engineering , Moutai Institute , Renhuai , 564507 , China.

Toxicology Research
|April 19, 2019
PubMed

Insights

Exposure to fine particulate matter (PM2.5) causes neurodegenerative disease-like changes in mice. Vitamin E (Vit E) administration blocked these effects by reducing oxidative stress and inflammation.

Area of Science:

  • Environmental Health
  • Neuroscience
  • Toxicology

Background:

  • Neurodegenerative diseases (ND) pose a significant global health challenge, with genetic factors alone insufficient to explain their pathogenesis.
  • Environmental factors and lifestyle choices are increasingly recognized as contributors to ND development.
  • Particulate matter (PM2.5) exposure is a potential environmental risk factor for ND, but underlying mechanisms require further investigation.

Purpose of the Study:

  • To investigate the in vivo effects of PM2.5 exposure on the brain and explore potential molecular mechanisms.
  • To assess whether vitamin E (Vit E) can mitigate PM2.5-induced neurotoxicity.

Main Methods:

  • C57BL/6J mice were exposed to PM2.5 daily for one week.
  • Neurobehavioral tests were conducted to evaluate cognitive function.
  • Histopathological examination of brain tissue was performed to detect neuronal loss and protein aggregates.
  • Biochemical assays were used to assess oxidative stress and inflammation markers.
  • The protective effects of concurrent vitamin E administration were evaluated.

Main Results:

  • Acute PM2.5 exposure induced cognitive deficits, neuronal loss, and protein aggregates in mouse brains, indicative of ND-like changes.
  • Evidence suggests that oxidative stress and inflammation are involved in PM2.5-induced neurotoxicity.
  • Concurrent administration of vitamin E significantly blocked the observed PM2.5-induced brain damage and associated pathologies.

Conclusions:

  • PM2.5 exposure can trigger neurodegenerative disease-like alterations in the brain through oxidative stress and inflammation.
  • Vitamin E demonstrates a protective effect against PM2.5 neurotoxicity, likely via its antioxidant and anti-inflammatory properties.
  • These findings highlight the potential role of air pollution in neurodegeneration and suggest therapeutic avenues for mitigation.

Related Concept Videos

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.2K
Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
2.4K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
839
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
630
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
611
Cholinergic Antagonists: Pharmacokinetics01:24

Cholinergic Antagonists: Pharmacokinetics

Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations,  while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
922